AHR and chronic kidney disease: IS downregulates the expression of the Mas receptor, which is associated with the inhibition of the renin-angiotensin system, via the organic anion transporter 3/AhR/STAT3 pathway to upregulate TGF-β in proximal tubular cells, thereby aggravating CKD (Ng et al., 2014).